Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Innovative Pharmaceutical Biotech ( (HK:0399) ) is now available.
Starcoin Group Limited has announced a Fourth Deed of Amendment to the terms of its Convertible Bonds, which includes changes such as extending the maturity date to July 2030, reducing the conversion price, and adjusting the interest rate. This amendment, which constitutes a connected transaction, has been approved by the board and is considered to be on fair and reasonable terms, beneficial to the company and its shareholders. The changes are subject to approval by the Stock Exchange and a special general meeting will be convened for this purpose.
More about Innovative Pharmaceutical Biotech
Starcoin Group Limited, formerly known as Innovative Pharmaceutical Biotech Limited, is a company incorporated in the Cayman Islands and continued in Bermuda with limited liability. It is involved in the pharmaceutical and biotech industry, focusing on innovative solutions and products.
Average Trading Volume: 23,347,140
Technical Sentiment Signal: Sell
Current Market Cap: HK$267.8M
For a thorough assessment of 0399 stock, go to TipRanks’ Stock Analysis page.